ONCO - Onconetix, Inc.
0.6664
-0.061 -9.199%
Share volume: 1,143,088
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.73
-0.06
-0.08%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 06-12-2025 | 11-13-2025 | 03-13-2026 | |
| Assets | ||||
| Total Assets | 18.776 M | 19.679 M | 24.927 M | |
| Current Assets | 2.421 M | 1.302 M | 6.067 M | |
| Inventories | 155.660 K | 151.556 K | 149.961 K | |
| Other Current Assets | 0.000 | 0.000 | 48.774 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.577 M | 836.556 K | 5.221 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 55.805 K | 40.388 K | 37.085 K | |
| Other Assets | 16.299 M | 18.336 M | 18.774 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 18.776 M | 19.679 M | 24.927 M | |
| Total liabilities | 14.258 M | 16.303 M | 9.160 M | |
| Total current liabilities | 14.039 M | 16.303 M | 9.136 M | |
| Accounts Payable | 2.582 M | 1.804 M | 1.758 M | |
| Other liabilities | 52.884 K | 53.149 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 52.884 K | 53.149 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.993 M | 3.374 M | 15.765 M | |
| Common stock | 132.631 M | 141.431 M | 147.836 M | |
| Retained earnings | -125.400 M | -136.884 M | -131.215 M |